Sombat Treeprasertsuk
Appearances
- DateMay 6, 2023BACKGROUND: Hepatic encephalopathy (HE) is associated with increased mortality, falls, and frequent hospitalizations. Patient reported outcomes (PROs) are useful tools to assess health-related quality of life (HRQOL) measures such as impairment of sleep, cognition, or activity…
Presenter
Speakers
Institute of Liver and Biliary Sciences - DateMay 9, 2023BACKGROUND: Due to development of an immune dysregulated phenotype, advanced liver disease in all its forms predisposes to sepsis acquisition and related mortality…
Presenter
- DateMay 8, 2023BACKGROUND AND AIMS: Screening tools are needed for early detection of NAFLD-fibrosis. We aimed to identify risk factors for NAFLD-fibrosis in the multiethnic population of the U.S. and thus accelerate development of equitable screening tools…
- DateMay 19, 2024BACKGROUND: Atezolizumab plus bevacizumab (ATEZO/BEV) and lenvatinib (LEN) have shown efficacy as first-line systemic treatments for unresectable hepatocellular carcinoma (HCC) in previous studies…
- DateMay 21, 2024Multidrug-resistant bacterial infections (MDR-BI) are emerging problems and associated with poor outcomes in cirrhotic patients. This study aimed to identify risk factors and assess efficacy of empirical antibiotics (ATB) in cirrhotic patients with MDR-BI…